Tag archive for ‘Teva Copaxone’
Globes On Monday, January 26th, 2015

Teva gets first “Sell” recommendation

Berenberg analysts see insurance companies pressuring MS patients to switch to generic versions of Copaxone. Last year, Teva Pharmaceutical Industries Ltd. (NYSE: TEVA; TASE: TEVA) posted its highest return More...

Wordpress site Developed by Fixing WordPress Problems